1361415-85-1

Upstream product

• 1241914-87-3 (4-fluorophenyl)(4-(5-methyl-1H-pyrazol-3-ylamino)quinazolin-2-yl)methanol 
• 1241914-72-6 (4-chloroquinazoline-2-yl)(4-fluorophenyl)methanone 
• 1241914-71-5 (4-fluorophenyl)(4-(5-methyl-1H-pyrazol-3-ylamino)quinazolin-2-yl)methanone 
• 34632-69-4 ethyl 4-chloro-quinazoline-2-carboxylate 
• 352-13-6 4-flourophenylmagnesium bromide 

Downstream Products

• 1453805-28-1 (R)-(4-fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol esylate salt 

Relevant academic research and scientific papers

SOLID FORMS COMPRISING OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, COMPOSITIONS THEREOF, AND USES THEREWITH

Solid forms comprising pyrazolylaminoquinazoline, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders are disclosed.

OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

Provided herein is an optically active pyrazolylaminoquinazoline, and pharmaceutical compositions thereof. Also provided herein is a method for treating, preventing, or ameliorating one or more symptoms of a JAK-mediated condition, disorder, or disease. F